Lisa Mucha, PhD

Articles by Lisa Mucha, PhD

Cost Sharing and Branded Antidepressant Initiation Among Patients Treated With Generics

ByJason D. Buxbaum, MHSA,Michael E. Chernew, PhD,Machaon Bonafede, PhD,Anna Vlahiotis, MA,Deborah Walter, MPA,Lisa Mucha, PhD,A. Mark Fendrick, MD

April 13th 2018

Higher cost sharing is associated with reduced branded antidepressant initiation among patients trying generic therapy. Dynamic benefit designs could enhance access to branded medications when appropriate.

Racial Differences in Switching, Augmentation, and Titration of Lipid-lowering Agents by Medicare/Medicaid Dual-eligible Patients

ByTami L. Mark, PhD, MBA,Kirsten J. Axelsen, MS,Lisa Mucha, PhD,Yelena Sadkova, MS

June 1st 2007

Lisa Mucha, PhD

Articles by Lisa Mucha, PhD

Cost Sharing and Branded Antidepressant Initiation Among Patients Treated With Generics

Racial Differences in Switching, Augmentation, and Titration of Lipid-lowering Agents by Medicare/Medicaid Dual-eligible Patients

Latest Updated Articles

Trending on AJMC

5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug

Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care

GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis

ICER Draft Flags High Cost of New Hypertension Drug Class

Iberdomide Approval Elevates MRD’s Role in Myeloma: Prerna Mewawalla, MD